Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-14

Clinical Trial Update: Decoding Pain Sensitivity in Migraine With Multimodal Brainstem-based Neurosignature [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update exploring pain sensitivity in migraine using multimodal brainstem-based neurosignature.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Migraine | Phase 4 | Status: UNKNOWN